<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Background radiation":1,
"Central nervous system tumours (CNS)":1,
"Child":2,
"Ecological study":1,
"Gamma radiation":1,
"Leukaemia":1,
"Neoplasm":2,
"Vertebroplasty":1,
"pain management":1,
"palliative treatment":1,
"radiofrequency ablation":2,
"thyroid carcinoma":11,
"Breast neoplasms":1,
"Intrinsic subtype":1,
"Prognosis":12,
"Young women":1,
"MALT lymphoma":1,
"diffuse large B-cell lymphoma":1,
"lymphomas":1,
"neck masses":1,
"primary thyroid lymphoma":1,
"thyroid malignancies":1,
"Complex I":1,
"Heteroplasmy":1,
"Mitochondrial DNA mutations":1,
"Mitochondrial haplogroup":1,
"Oncocytic tumors":1,
"Clinical characteristics":1,
"Parathyroid adenoma":2,
"Parathyroid carcinoma":1,
"Parathyroid hyperplasia":1,
"Primary hyperparathyroidism":1,
"Autoimmune thyroiditis":1,
"Normoechogenic background of thyroid gland":1,
"Papillary thyroid carcinoma":19,
"Ultrasonography of thyroid gland":1,
"Adolescents":1,
"Children":1,
"Follicular thyroid cancer":2,
"Pediatric thyroid cancer":1,
"Surgery":2,
"Anaplastic thyroid cancer":3,
"EIF1AX":1,
"Poorly differentiated thyroid cancer":1,
"RAS":2,
"Thyroid cancer":32,
"Central neck dissection":2,
"Esvaziamento cervical central":1,
"Local recurrence":1,
"Meta-analysis":3,
"Metanálise":1,
"Microcarcinoma papilífero de tireoide":1,
"Papillary thyroid microcarcinoma":2,
"Recidiva local":1,
"Ablation techniques":1,
"High-intensity focused ultrasound ablation":1,
"Interventional ultrasonography":1,
"Treatment efficacy":1,
"Ultrasound imaging":1,
"TIRADS":1,
"hyperfunctioning thyroid nodules":1,
"thyroid nodules":8,
"thyroid scintigraphy":1,
"Familial medullary thyroid carcinoma":1,
"MAP2K1/2-ERK1/2 signaling":1,
"MAP2K5-ERK5 signaling":1,
"familial non-medullary thyroid carcinoma":1,
"parathyroid scintigraphy, 99mTc-sestamibi, ultrasound":1,
"parathyroidectomy":1,
"hybrid filtering":1,
"image despeckling":1,
"morphometry":1,
"segmentation":1,
"thyroid nodule":8,
"ultrasound image":1,
"Cancer":15,
"Cohort study":1,
"Diabetes":1,
"Record linkage":1,
"Area Under Curve":1,
"Diagnosis":5,
"Nomogram":1,
"Ultrasonography":2,
"FASN":1,
"PKM2":1,
"SREBP-1c":1,
"bladder cancer cells":1,
"p-AKT":1,
"p-mTOR":1,
"lung cancer":1,
"podoplanin-positive cancer-associated fibroblasts":1,
"worse outcome":1,
"BRAF mutation":2,
"Singapore":1,
"Southeast Asian":1,
"destructive thyroiditis":2,
"hepatocellular carcinoma":3,
"hyperthyroidism":2,
"lenvatinib":3,
"antithyroglobulin antibody":1,
"antithyroidperoxidase antibody":1,
"recurrence":4,
"cardiovascular":1,
"cross sectional studies":1,
"endocrine disrupters":1,
"epidemiology":4,
"Effective Half-life":1,
"Radioiodine Therapy":3,
"Renal insufficiency":1,
"eGFR":1,
"Cytology":5,
"INSM1":1,
"Immunohistochemistry":7,
"Small cell lung cancer":1,
"p16":1,
"Hipocalcemia":1,
"Hipoparatiroidismo":1,
"Hypocalcemia":2,
"Hypoparathyroidism":1,
"Parathormone":1,
"Paratohormona":1,
"Thyroidectomy":7,
"Tiroidectomía":1,
"Aggressiveness":1,
"ID genes":1,
"bHLH":1,
"Foxp3":1,
"GARP":1,
"Adipokine":1,
"Adiponectin":1,
"Biomarker":3,
"Inflammation":2,
"Microbiome":1,
"Obesity":2,
"Resistin":1,
"Visfatin":1,
"Carcinoma":3,
"Giant cells":1,
"Lung":1,
"Osteoclast":1,
"hypophysitis":1,
"lung adenocarcinoma":3,
"nivolumab":2,
"secondary adrenal insufficiency":1,
"CDX2":1,
"Islet 1":1,
"Liver metastasis":1,
"Neuroendocrine neoplasia":1,
"Serotonin":1,
"DNA-dependent protein kinase activity":1,
"DNA-dependent protein kinase catalytic subunit":1,
"predictive assay":1,
"radiosensitivity":1,
"thyroid cancer cell":1,
"contrast enhanced ultrasound":1,
"elastography":1,
"logistic regression":1,
"multimodality":1,
"metastatic":1,
"pancreas":2,
"papillary":1,
"thyroid":14,
"Strumal carcinoid":1,
"immunocytochemistry":1,
"ovary":1,
"malignancy":2,
"pathologic size":1,
"ultrasound size":1,
"Lymph node metastasis":1,
"Radioiodine-131":1,
"Thyroglobulin level":1,
"Treatment outcome":1,
"Fine-needle aspiration (FNA)":2,
"Indeterminate nodules":1,
"Risk of malignancy":1,
"endoscopic thyroidectomy":1,
"remote access thyroidectomy":1,
"robotic thyroidectomy":1,
"transoral thyroidectomy":1,
"Distant metastasis at surgery":1,
"Medullary thyroid carcinoma (MTC)":1,
"Overall survival":1,
"Programmed cell death protein 1 (PD-1)":1,
"Programmed death-ligand 1 (PD-L1)":1,
"Progression free survival":1,
"cervical lymph node":1,
"metastasis":4,
"post-thyroidectomy":1,
"three-dimensional ultrasound":1,
"MAPK/ERK pathway":1,
"PI3K/AKT pathway":1,
"TBX1":1,
"epithelial–mesenchymal transition":1,
"completion thyroidectomy":1,
"complications":1,
"differentiated thyroid cancer":3,
"hemithyroidectomy":1,
"total thyroidectomy":4,
"false-negative":1,
"fine-needle aspiration":3,
"head and neck nodules":1,
"pathologic diagnosis":1,
"Fistula":1,
"Hyoid":1,
"Osteoradionecrosis":1,
"Radiation therapy":1,
"ThyroSeq":2,
"benign call rate":1,
"molecular testing":2,
"rule-out test":1,
"Molecular profile":1,
"Tall cell variant":1,
"Carcinoma diferenciado de tiroides":1,
"Castilla-La Mancha":1,
"Differentiated thyroid carcinoma":3,
"España":1,
"Spain":1,
"Follicular thyroid adenoma":1,
"Genetics":1,
"Indeterminate cytology":2,
"Molecular diagnosis":1,
"Next-generation sequencing":3,
"18F-choline":1,
"Incidentaloma":1,
"PET/CT":2,
"insulin resistance":1,
"metformin":1,
"systematic review":1,
"thyrotropin":3,
"Benign thyroid disease":1,
"Radioiodine uptake test":1,
"Thyroid stunning":1,
"Endocrine disrupting chemicals":1,
"Environment":1,
"Pollutants":1,
"Risk assessment":1,
"anti-thyroid antibodies":1,
"autoimmune factors":1,
"hyperprolactinemia":1,
"interleukins":1,
"macroprolactinemia":1,
"prolactin":1,
"NADPH oxidase":1,
"dedifferentiation":1,
"genetic instability":1,
"oxidative stress":1,
"Liver":1,
"Survival":3,
"Denmark":1,
"biochemical cure":1,
"medullary thyroid carcinoma":3,
"nationwide":1,
"population-based":1,
"centrifugation":1,
"cytopathology":1,
"droplet digital polymerase chain reaction":1,
"liquid biopsy":2,
"molecular":1,
"mutation profiling":1,
"supernatant":1,
"5-Fluorouracil":1,
"Cisplatin":1,
"Docetaxel":1,
"Esophageal squamous cell carcinoma":1,
"Neoadjuvant chemoradiotherapy":1,
"Borderline/precursor tumor":1,
"Observer variation":1,
"RAS-like tumor":1,
"anaplastic":2,
"medullary":1,
"radioiodine-refractory differentiated thyroid cancer":1,
"Elderly":1,
"Mortality":3,
"Risk factors":2,
"BRAF-like":1,
"Follicular variant papillary thyroid carcinoma":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features":1,
"RAS-like":1,
"body mass index":1,
"metabolic health":1,
"Slit homolog 2 protein":1,
"Chemoradiotherapy":2,
"Chemotherapy":1,
"Resection":1,
"M918V variant":1,
"MEN2":1,
"RET gene":1,
"medullary thyroid cancer":2,
"metabolomics":1,
"Depression":1,
"Thyroid disease":2,
"Women’s health":1,
"PI3K/AKT signalling pathway":1,
"STAT3":1,
"lncRNA ABHD11-AS1":1,
"miR-1301-3p":1,
"BRAFV600E mutation":1,
"CD68":1,
"tumor-associated macrophages":1,
"BET inhibitors":1,
"Papillary thyroid cancer":7,
"phospho-AKT":1,
"siRNA anti-hTERT":1,
"Hürthle cell lesion":1,
"Hürthle cell neoplasm":1,
"Hürthle cell type":1,
"atypia of undetermined significance/follicular lesion of undetermined significance":1,
"follicular neoplasm":1,
"risk of malignancy (ROM)":1,
"risk of neoplasia (RON)":1,
"the Bethesda System for Reporting Thyroid Cytopathology":1,
"cancer risk":1,
"germline":1,
"renal cell carcinoma":1,
"succinate dehydrogenase complex":1,
"variant interaction":1,
"variants of uncertain significance":1,
"Breast cancer":3,
"CLSM":1,
"FT-IR analysis":1,
"Graphene oxide":1,
"Western blotting":1,
"Cell Biology":1,
"Oncogenes":1,
"Oncology":2,
"free thyroxine":1,
"iodine sufficiency":1,
"pregnancy":1,
"diagnostic pathways":1,
"micro-papillary cancer":1,
"over-diagnosis":1,
"population-based sample":1,
"circ_0025033":1,
"circular RNA":1,
"miR-1231":1,
"miR-1304":1,
"Breg":1,
"IL-10":1,
"Systemic lupus erythematosus":1,
"lymphoma":1,
"multiple myeloma":1,
"risk":1,
"Classification":2,
"Genotype-phenotype correlations":1,
"Histomorphology":1,
"BRAF V600E mutation":1,
"Genetic molecular marker":1,
"RAS mutation":1,
"Risk stratification":2,
"TERT promoter Mutation":2,
"Intraoperative neuro monitoring":1,
"Recurrent laryngeal nerve":1,
"Thyroid anatomy":1,
"Thyroid surgery":1,
"Lymph node":2,
"Neck dissection":1,
"Conventional":1,
"Robotic endoscopic thyroidectomy":1,
"Central node dissection":1,
"Feasibility":1,
"Outcomes":2,
"Safety":1,
"Surgical technique":1,
"TOETVA":1,
"Transoral endoscopic thyroidectomy, vestibular approach":1,
"Definitions":1,
"Dosages":1,
"Dosimetry":1,
"Indications":1,
"Radioiodine":2,
"Recombinant human TSH":1,
"Therapy":2,
"Management":1,
"Microcarcinoma":1,
"Shared decision-making":1,
"Active surveillance":1,
"Guidelines":1,
"Lifetime probability of disease progression":1,
"Medical cost":1,
"Unfavorable events":1,
"Bone":1,
"Cardiovascular system":1,
"Levothyroxine":2,
"Environmental exposure":1,
"Incidence":2,
"Cancer recurrence":1,
"Serum thyroglobulin monitoring":1,
"Thyroid cancer imaging":1,
"Angiogenesis":1,
"Immunotherapy":3,
"MEK kinases":1,
"Mitogen-activated protein kinases":1,
"Protooncogene protein TRK":1,
"Receptor tyrosine kinase RET":1,
"TOR serine-threonine kinases":1,
"Thyroid neoplasms":2,
"Multimodality therapy":1,
"Systemic therapy":1,
"CEA":1,
"Calcitonin":1,
"MEN":1,
"RET":3,
"BRAF(V600E)":1,
"CDKN2A":1,
"Microenvironment":1,
"PAX8/PPRγ":1,
"hTERT":1,
"Ultrasound":3,
"Afirma":1,
"Response to therapy":1,
"Cervus nippon yesoensis":1,
"biphasic":1,
"pulmonary adenofibroma":1,
"sika deer":1,
"Checkpoint inhibition":1,
"Head and neck squamous cell carcinoma":1,
"Human papillomavirus":1,
"PD-L1":2,
"poorly differentiated":1,
"presentation":1,
"Brazil":1,
"multiple endocrine neoplasia":1,
"pheochromocytoma":1,
"CD133":1,
"Cancer stem cells":1,
"SLC1A3":1,
"Self-renewal":1,
"Carcinoma tiroideo":1,
"Ganglio centinela":1,
"Paramagnetic tracer":1,
"Sentinel node":1,
"Trazador paramagnético":1,
"Cervical lymph node metastases":1,
"Radionuclide imaging":1,
"Sodium pertechnetate Tc 99m":1,
"Mice, transgenic":1,
"Proto-oncogene proteins B-raf":1,
"Cancer registries":1,
"Consensus":1,
"Very rare paediatric cancers":1,
"Baicalein":1,
"FRO cell":1,
"MAPK/Akt pathway":1,
"apoptosis":5,
"ABCC4":1,
"adriamycin":1,
"miR-124-3p":1,
"sensitivity":1,
"angioleiomyoma":1,
"head and neck neoplasms":1,
"surgical procedures,operative":1,
"IDH":1,
"Molecular epidemiology":1,
"Oligodendroglioma":1,
"rs55705857":1,
"Diabetic ketoacidosis":1,
"Hypothyroidism":1,
"Myxedema coma":1,
"Anti–PD-1":1,
"PD-1":1,
"Pembrolizumab":1,
"MiR-144-3p":1,
"Microarray":1,
"Non-small cell lung cancer":1,
"Quantitative real-time PCR":1,
"miRNA-sequencing":1,
"Crotonylation":1,
"HCC":1,
"HDAC":2,
"diagnostic biomarkers":1,
"exosomes":1,
"extracellular vesicles":1,
"miRNA":1,
"histone deacetylase inhibitors":1,
"review":1,
"Lobectomy":1,
"Survival rate":2,
"Cancer biology":1,
"Gene expression":2,
"Neuroendocrine signature":1,
"Sinonasal epithelial cancer":1,
"Tumor microenvironment":1,
"Autophagy":2,
"Thyroid hormone":1,
"Thyroid hormone receptor":1,
"non-alcoholic fatty liver disease":1,
"Bilateral":1,
"Multifocal":1,
"In-situ preservation":1,
"Robotic surgery":1,
"Subcapsular parathyroid gland":1,
"Super-meticulous capsular dissection":1,
"diffusion-weighted imaging":2,
"head and neck cancer":3,
"quantitative Imaging":1,
"repeatability":1,
"within-subject coefficient of variation":1,
"Gaussian and non-Gaussian":1,
"multi b-value":1,
"tumor aggressiveness":1,
"Cohort":1,
"Occupational exposure":1,
"Radiation":1,
"Thyroid gland":2,
"Workers":1,
"bioelectrical impedance spectroscopy":1,
"breast neoplasm":1,
"intraoperative detection":1,
"pathological examination":1,
"Case report":2,
"Multiple endocrine tumors":1,
"Paraganglioma":1,
"Chronic kidney disease":1,
"Comorbidity":1,
"Neoplasms":1,
"Cholangiocarcinoma":1,
"HDAC3":1,
"Pyruvate":1,
"cMyc":1,
"TGF-β1":1,
"invasion":3,
"lncRNA-NEF":1,
"migration":1,
"human breast cancer":1,
"mammary carcinogenesis":1,
"milk fat globule-EGF factor 8":1,
"Anastomosis":1,
"Radial incision and cutting":1,
"Rectal stenosis":1,
"Rectal stricture":1,
"Transanal minimally invasive surgery":1,
"methylation":1,
"proto-oncogene":1,
"endocrinology":1,
"haematology (incl blood transfusion)":1,
"epithelial-mesenchymal transition":1,
"long noncoding RNA H19 (lncRNA H19)":1,
"Grave's disease":1,
"Hashimotos's thyroiditis":1,
"autoantibodies":1,
"autoantigens":1,
"lymphocytic infiltration":1,
"2019":1,
"Adult":1,
"Canada":1,
"Female":1,
"Fine needle aspiration biopsy":1,
"Haematoxylin and eosin staining":1,
"Histopathology":1,
"Insight into disease pathogenesis or mechanism of therapy":1,
"Lymph node dissection":1,
"March":1,
"Radiotherapy":3,
"TSH":1,
"Thyroid antibodies":1,
"Thyroid function":1,
"Thyroid ultrasonography":1,
"Tumours and neoplasia":1,
"Ultrasound-guided biopsy":1,
"White":1,
"DNA methylation":1,
"PFKFB2":1,
"well-differentiated thyroid carcinoma":1,
"Cyclin D1":1,
"NGS":1,
"Aspiration":1,
"Head-and-neck cancer":1,
"Larynx":1,
"Autonomous functioning thyroid nodules":1,
"Endocrine abnormalities":1,
"Screening":1,
"Syndromic diseases":1,
"convolutional neural network":1,
"deep learning":1,
"hyperspectral imaging":1,
"optical biopsy":1,
"squamous cell carcinoma":1,
"β-hydroxybutyrate":1,
"Bethesda system":1,
"FNA":1,
"Minimally invasive surgery":1,
"Percutaneous laser ablation":1,
"Thyroid micropapillary carcinoma":1,
"programmed cell death 1":1,
"programmed cell death ligand 1":1,
"De-differentiation":1,
"Microfluidics":1,
"Viability":1,
"cancer- risk factors":1,
"HOMA-IR":1,
"vitamin D":1,
"Human leukocyte antigen":1,
"Hydrocortisone":1,
"Isolated adrenocorticotropic hormone deficiency":1,
"Thyroiditis":1,
"Genome":1,
"High-throughput nucleotide sequencing":1,
"Thyroid cancer, follicular":1,
"Thyroid cancer, papillary":2,
"Transcriptome":1,
"TIRADS classification":1,
"sonoelastography":1,
"NDAT":1,
"anticancer":1,
"colorectal cancer cells":1,
"integrin αvβ3":1,
"perfusion bellows cell culture system":1,
"phosphoERK1/2":1,
"tetrac":1,
"Adverse events":1,
"Plasma concentration":1,
"Polymorphism":1,
"UGT1A1":1,
"carcinogenesis":1,
"carcinogenic":1,
"overweight":1,
"Neutrophil to lymphocyte ratio":1,
"Prognostic factor":1,
"Programmed death ligand 1":1,
"Pyruvate kinase M2":1,
"131I empiric therapy":1,
"thyroglobulin":1,
"whole body scan":1,
"AKT/ERK":1,
"epidermal growth factor receptor":1,
"tissue factor":1,
"tumor growth":1,
"Thyroglossal Duct Cyst":1,
"Neutrophil-to-lymphocyte ratio":1,
"platelet-to-lymphocyte ratio":1,
"false-positive":1,
"iodine":2,
"I-131":1,
"Completion&nbsp":1,
"Differentiated thyroid cancer (DTC)":1,
"Papillary carcinoma thyroid (PCT)":1,
"Revision surgery":1,
"propensity score matching":1,
"MT1M":1,
"PTC":1,
"Childhood leukemia":1,
"hematopoietic stem cell transplantation":1,
"late-effects":1,
"long-term follow-up":1,
"total body irradiation":1,
"RECK":1,
"miR-221":1,
"Bone metastasis":1,
"Mucoepidermoid":1,
"Mucoepidermoid carcinomas":1,
"EMT":1,
"UBE2C":1,
"ZEB1/2":1,
"cellular growth":1,
"lung cancer metastasis":1,
"miR-548e-5p":1,
"AKT signaling":1,
"TUSC3":1,
"colon cancer":1,
"miR-873-5p":1,
"I131 therapy":1,
"residual thyroid volume":1,
"three-dimensional reconstruction":1,
"diagnostic biomarker":1,
"irisin":1,
"Laparoscopic surgery":1,
"Ovarian diseases":1,
"Small-cell lung carcinoma":1,
"Thyroglossal cyst":1,
"papillary carcinoma":1,
"VEGF-A":1,
"angiogenic factor":1,
"histopathological factors":1,
"discrepancy":1,
"histology":1,
"SNHG15":1,
"long noncoding RNA":1,
"Adenocarcinoma, follicular":1,
"Follow-up studies":1,
"IMRT":1,
"VMAT":1,
"Volumetric modulated arc therapy":1,
"Whole lung irradiation":1,
"Wilms’ tumor":1,
"GAB2":1,
"miR-125a-5p":1,
"proliferation":2,
"recurrent laryngeal nerve paralysis":1,
"two-stage resections":1,
"177Lu-DOTATATE":1,
"18F-fluorodeoxyglucose":1,
"68Ga-DOTATATE":1,
"carcinoma larynx":1,
"dual tracer positron emission tomography-computed tomography":1,
"large cell neuroendocrine carcinoma":1,
"peptide receptor radionuclide therapy":1,
"Beclin-1":1,
"thyroid carcinoma cells":1,
"association":1,
"post-traumatic stress disorder":1,
"serotonin-transporter-linked polymorphic region gene":1,
"SETD7":1,
"miR-345-5p":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年3月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
